Back to top

Myriad Genetics, Inc. Enters Oversold Territory
February 08, 2013

Read MoreHide Full Article

Myriad Genetics, Inc.’s (MYGN - Free Report) share price has entered into oversold territory with a stochastic value of 17.8110. The Zacks Consensus Estimate on the company’s earnings for year ending June 2013 increased by 4 cents over the past week to $1.58 per share. Myriad Genetics, Inc. is a Zacks Rank #1 (“Strong Buy”) company.

 




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Myriad Genetics, Inc. (MYGN) - free report >>


More from Zacks Tale of the Tape

You May Like